McPherson's swings to net loss in FY26
- McPherson's logged a 14.9% revenue drop to $118.3 million alongside a statutory net loss of $20.3 million for FY26.
- The board will not pay a full-year dividend following the net cash contraction from $8.8 million down to $4.5 million.
- Operational supply chain shifts and retail channel disruption drove the sales decline across core personal care brands.
McPherson's (ASX:MCP) reported full-year revenue fell 14.9% to $118.3 million as statutory net loss expanded to $20.3 million.
The company faced operational challenges as the shift to a pharmacy wholesaler distribution model caused higher disruption than anticipated across retail channels.
The business acknowledged performance was below expectations due to transition delays in the independent pharmacy market and out-of-stock issues.
Brett Charlton, CEO & Managing Director said, “Our priorities for FY27 are clear: accelerating growth by investing behind our brands, customers, innovation pipeline and e-commerce capabilities.”
Material items totalled $25.6 million for the period, which included $23.5 million in non-cash impairment charges.
Following the announcement, the McPherson share price was down at $0.150.
The entity stated the new operational framework delivered $2.8 million in route-to-market cost savings at the underlying earnings level.
The health and beauty product supplier retains undrawn debt facilities while maintaining digital brand platforms to support future direct-to-consumer expansion.
